A Study of Biological, Pathological and Imagery Markers in the First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma With Sunitinib BEFORE and AFTER Nephrectomy
Latest Information Update: 09 Nov 2021
At a glance
- Drugs Sunitinib (Primary)
- Indications Renal cell carcinoma
- Focus Biomarker; Therapeutic Use
- Acronyms PREINSUT
- 30 Jul 2018 Results published in the Clinical Cancer Research
- 17 Sep 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 11 Jul 2009 New trial record